Free Trial
→ Alert: Prepare for Trump's Dollar Overhaul (From Brownstone Research) (Ad)tc pixel

ICAP Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at ICAP. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by ICAP.

Brokerage Ranking
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Total Ratings
0 Last 12 Months
Buy Ratings
0 Last 12 Months
Sell Ratings
0 Last 12 Months
United States flag
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
Export to Excel
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$189.76
+6.5%		4/19/2021 Boost Price Target$130.00 ➝ $160.00View details for ICAP rating of Applied Materials (NASDAQ:AMAT) on 4/19/2021
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$189.76
+6.5%		1/10/2020 UpgradeNeutral ➝ BuyView details for ICAP rating of Applied Materials (NASDAQ:AMAT) on 1/10/2020
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$145.66
+2.1%		9/4/2018 Lower Price Target$140.00 ➝ $128.00OutperformView details for ICAP rating of Neurocrine Biosciences (NASDAQ:NBIX) on 9/4/2018
Lam Research Corporation stock logo
LRCX
Lam Research
$126.32
+3.6%		1/25/2018 Reiterated Rating$24.00Positive ➝ BuyView details for ICAP rating of Lam Research (NASDAQ:LRCX) on 1/25/2018
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$145.66
+2.1%		2/10/2017 Reiterated Rating$55.00OutperformView details for ICAP rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/10/2017

MarketBeat Community Rating for ICAP

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  53,564 (Vote Outperform)
Underperform Votes:  51,132 (Vote Underperform)
Total Votes:  104,696
MarketBeat's community ratings are surveys of what our community members think about ICAP and other research firms. Vote "Outperform" if you believe ICAP's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICAP's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.
Today's Ratings
Top-Rated Stocks
More Ratings Tools